Corporate Profile
| Established | January 29, 1954 |
|---|---|
| Head Office | 5-13-9, Nishinakajima, Yodogawa-ku, Osaka, 532-0011, Japan |
| Officers | Kamal Kishore Sharma, Chairman and Representative Director Ray Tsunoda, President and Representative Director Yoshiro Mukai, Vice President and Representative Director Vinod Dhawan, Representative Director |
| Capital | 101 million yen |
| Sales | 12.3 billion yen (Fiscal year ended March 31, 2012) |
| Employees | 408 (As of May 31, 2012) |
| Business Activities | Development, production, marketing and import/export of pharmaceutical products |
| Affiliations | The Federation of Pharmaceutical Manufacturers' Associations、
Japan Generic Medicines Association、 Osaka Pharmaceutical Manufacturers Association |
| Main Clients Financial Institutions |
The Bank of Tokyo-Mitsubishi-UFJ Resona Bank The Senshu Ikeda Bank The Kinki Osaka Bank The Shoko Chukin Bank |
| Business Locations | Sanda Manufacturing Plant / Research Center |
| Subsidiaries | I'rom Pharmaceutical Co., Ltd (external site) |
History
| January, 1954 | Founded in Osaka as an OTC company |
|---|---|
| March, 1964 | Commencement of generic drug business |
| January, 1968 | Head office and plant moved to Takatsuki |
| June, 1988 | Head office moved to Shin-Osaka |
| November, 1989 | Manufacturing plant established in Sanda, Hyogo |
| October, 1995 | Plant expanded to double production capacity |
| April, 1996 | Commencement of strategic focus on psychiatric and neurological pharmaceutical products through major recruitment of medical representatives and visits to psychiatric hospitals in metropolitan areas. |
| March, 1997 | Research Center established in Sanda, Hyogo |
| July, 1998 | Reinforcement of psychiatric and neurological pharmaceutical product portfolio and nationwide deployment of therapeutic focus strategy through acquisition of all generic pharmaceutical products of Boehringer Mannheim K.K. |
| September, 2001 | Acquisition of Ospolot business from Bayer and start of branded generic business |
| May, 2003 | Acquisition of marketing rights of generic pharmaceutical products of Uji Pharmaceutical Co., Ltd. |
| October, 2004 | Acquisition of marketing rights of pharmaceutical products of MG PHARMA Incorporation. |
| May, 2005 | Outsourcing of distribution operation for all pharmaceutical products to Yamato Logistics Co., Ltd |
| July, 2005 | Collaboration Agreement with the Lupin Group. |
| October, 2007 | Capital alliance with the Lupin Group, with majority ownership of the company acquired by the Lupin Group. |
| November, 2008 | Became wholly-owned subsidiary of the Lupin Group. |
| December, 2010 | Increase in capital by 3 million yen to 101 million yen |
| May, 2011 | Relocation of logistics center from Kobe City to Amagasaki City in Hyogo Prefecture. |
| November, 2011 | Acquisition of all outstanding shares of I'rom Pharmaceutical Co., Ltd. |
